LA Private

Uncategorized

Treasury Wines uncorking profits

Treasury Wine Estates (ASX:TWE) has kicked off FY25 with impressive first-quarter results, highlighted by double-digit growth in net sales revenue (NSR). The company’s luxury-focused strategy continues to pay dividends, with strong performances across its key brands, particularly Penfolds and its newly acquired DAOU Vineyards. TWE reported that the Penfolds brand maintained solid momentum in both

Treasury Wines uncorking profits Read More »

Finbar delivers solid FY24 results, driven by Civic Heart completion

Finbar Group Limited (ASX:FRI), a leading property developer in Western Australia, has posted a strong performance for FY24, with a comprehensive income increase of $13.6 million, bringing total earnings to $16.4 million. The year was marked by the successful completion of the Civic Heart project in South Perth, which had a significant impact on the

Finbar delivers solid FY24 results, driven by Civic Heart completion Read More »

General Motors boosts investment in US lithium mine to nearly $1bn

General Motors (GM) has significantly increased its investment in a key lithium project, raising its total commitment to nearly $1 billion as it aims to secure a long-term supply of the critical metal essential for electric vehicle (EV) battery production. The US automaker has raised its stake in Vancouver-based Lithium Americas to $945 million from

General Motors boosts investment in US lithium mine to nearly $1bn Read More »

China’s “big” stimulus – will it work? And what does it mean for Australia?

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses China’s stimulus moves. Key points:A move towards more aggressive fiscal policy stimulus and property support measures should help drive a mild cyclical upswing in China’s economy.However, it’s doubtful it will be enough to reverse longer term structural problems facing China – around

China’s “big” stimulus – will it work? And what does it mean for Australia? Read More »

Enlitic prescribes AI for radiology growth

AI-powered healthcare company Enlitic (ASX:ENL) has secured two major distribution agreements with Bayer Healthcare and Philips Healthcare, further cementing its presence in the global medical imaging market. The three-year partnership with Bayer will integrate Enlitic’s ENDEX platform into Bayer’s radiation dose management software. This collaboration aims to improve radiation dose monitoring at radiology sites, with

Enlitic prescribes AI for radiology growth Read More »